Guidelines

New ** For a summary of changes to revised guidelines (2010-10-01), click here **

2-G-001 - Main Health Sciences REB Guidelines

2-G-002 - (formerly Appendix 1) - Risks Equivalents

2-G-003 - (formerly Appendix 2) - Use of Radiation

New
2-G-004 - (formerly Appendix 3) - Use of Magnetic Resonance Imaging

2-G-005 - (formerly Appendix 4) - Information & Consent Documentation

2-G-006 - (formerly Appendix 5) - Assent from Children

New
2-G-007 - (formerly Appendix 6) - Categories of Review

2-G-008 - (formerly Appendix 7) - Sponsor Documents

2-G-009 - Alternate Wording Glossary

2-G-010 - Emergency/Compassionate Release

2-G-011 - Exercise Protocols

2-G-012 - Muscle Biopsy

2-G-013 - N of 1 Studies

2-G-014 - Open Label Extension Studies

New
2-G-015 - Reporting Protocol Violations, Deviations & Waivers

2-G-017 - Study Documents - Confidentiality, Access & Ownership

2-G-018 - U.S. HIPAA Authorization Forms & Consent

2-G-019 - Use of Alcohol in Research

2-G-020 - Compensation for Child Participants

2-G-022 - Studies Involving Risks to Pregnant Women, a Foetus and/or Potential Fathers

2-G-023 - Placebos & Multiple Sclerosis Clinical Trials

2-G-024 - Protocols Already Approved by OCREB

2-G-025 - Recruitment of Healthy Volunteers

2-G-026 - Use of tissue and biological specimens and cadavers in research

2-G-027 - Release of Info Documentation

New
2-G-028 - Female Partner Sept 2009

2-G-029 - CT Registration & Dissemination Sept 2005

2-G-030 - HSREB Composition & Quorum

2-M-001 - Health Canada Attestation Form

2-M-002 - Investigations With Schedule C Drugs

More guidelines (Common to both HSREB and NMREB)